H.C. Wainwright reaffirmed its Buy rating and $18.00 price target for Valneva (EPA:VLS) SE (NASDAQ:VALN) shares, following the recent approval of the company's Ixchiq vaccine in the United Kingdom ...

Samantha Ruth Prabhu donned a translucent white short kurta-style top with a matching bralette. Ditching heavy accessories, ...

Sharing a picture of herself exercising, she wrote, “Recovering from Chikungunya is so fun. The joint pains and ALL.” Meanwhile, the diva seems to have planned out ‘tall ambitions’ for the ...

The project aimed to reduce the population of yellow fever-carrying mosquitoes in Queensland, also known as aedes aegypti academically, to prevent mosquito-borne disease outbreak. The species ...

A human case of H5N1 avian influenza has been detected in in the UK authorities have said.  It is the second symptomatic human case of H5N1 bird flu recorded in the UK, after the first was detected in ...

Valneva (VALN) stock gained as its chikungunya vaccine receives marketing authorization in the U.K., expanding the single-dose shot's global reach. Read more here.

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

Valneva (VALN) announced that the Medicines and Healthcare products Regulatory Agency or MHRA has granted marketing authorization in the United ...

Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing chikungunya disease in adults only, although it is in clinical ...

No writing assistance was utilized in the production of this manuscript. Chikungunya virus (CHIKV) causes an acute febrile disease characterized by severe arthralgia in the small joints.